NCT06636812View on ClinicalTrials.gov

Losartan and Emotional Processing in Young People

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Emotional Processing
Interventions
DRUG

Losartan potassium

Single dose losartan (25mg or 50 mg, weight-adjusted), encapsulated identically to placebo

OTHER

Placebo

Single tablet encapsulated identically to placebo

Trial Locations (1)

OX37JX

RECRUITING

Warneford Hospital, University of Oxford, Oxford

All Listed Sponsors
collaborator

Oxford Health Biomedical Research Centre (OH BRC) support scheme

UNKNOWN

lead

University of Oxford

OTHER